Welcome to LookChem.com Sign In|Join Free
  • or
methyl 2-(2-hydroxypropan-2-yl)benzofuran-5-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

69703-21-5

Post Buying Request

69703-21-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

69703-21-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 69703-21-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,7,0 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 69703-21:
(7*6)+(6*9)+(5*7)+(4*0)+(3*3)+(2*2)+(1*1)=145
145 % 10 = 5
So 69703-21-5 is a valid CAS Registry Number.

69703-21-5Downstream Products

69703-21-5Relevant academic research and scientific papers

Imidazole-containing condensed tricyclic compound and application thereof

-

Paragraph 0236, (2018/03/01)

The invention discloses an imidazole-containing condensed tricyclic compound adopting the structure as shown in the formula (I) or pharmaceutically acceptable salts, stereisomers or prodrug molecules thereof. The imidazole-containing condensed tricyclic compound has the IDO1 activity regulation function, can enhance T-cell activation through blocking immune checkpoints IDO1, is used for treating IDO1-mediated immunosuppression, and therefore, can become an effective medicine for treating malignant tumors. When used together with checkpoint protein anti-body drugs or other anti-cancer drugs, the imidazole-containing condensed tricyclic compound can enhance the anti-cancer effect. Meanwhile, the imidazole-containing condensed tricyclic compound has the potential of effectively treating IDO1 abnormity related immunosuppressive diseases and has a high application value.

BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 065

-

Page/Page column 61, (2009/05/28)

The invention provides compounds of formula wherein R1, R2, R3, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1

BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 066

-

Page/Page column 127, (2009/06/27)

The invention provides compounds of formula wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.

Solid phase synthesis of 2-substituted benzofurans via the palladium-catalysed heteroannulation of acetylenes

Fancelli, Daniele,Fagnola, Maria Chiara,Severino, Dino,Bedeschi, Angelo

, p. 2311 - 2314 (2007/10/03)

The copper/palladium-promoted heterannulation of terminal acetylenic compounds in the presence of resin bound ortho-hydroxy aryl iodides is described. The process produces 2-substituted benzofuran derivatives in good yield and high purity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 69703-21-5